SUOMEN TERVEYSTALO OYJ STOCK EXCHANGE RELEASE February 21, 2008 at 09.00 am Terveystalo centralizes its operations and sells its central laboratory to Medix Laboratoriot Oy Suomen Terveystalo Oyj has made its operations more efficient and will in future focus on customer serving sample taking laboratory operations and related analysis in its laboratory diagnostics operations. Terveystalo has sold its central laboratory operations to Medix Laboratoriot Oy. Cost efficient clinical analytics is based on the big volume of samples as well as the versatile offering of special analytics with the help of common logistics. For Terveystalo, strategic partnership with Finland's largest private central laboratory Medix Laboratoriot creates the conditions for further improving operational profitability both in the Occupational Healthcare segment and Clinics and Hospitals segment. Terveystalo estimates that its starting strategic partnership with Medix Laboratoriot in the area of mass analytics and special sample examination will amount to approximately EUR 0.5 million annual synergies. Terveystalo Group has the most extensive sample taking laboratory network in Finland. The laboratories that operate in clinic hospitals, clinics and occupational healthcare centers are not included in this transaction and will also in the future continue to make independent quick analytics which can be used, for instance, to rule out severe infections. Less urgent analytics and the examination of special will in the future be sourced from Medix Laboratoriot based on a strategic partnership. - This business divestment creates the conditions for us to develop cooperation based on laboratory samples and their examination with the country's leading private laboratory operator. This involves the strengthening of our sample taking laboratory operations at customer interface and quick analytics as a part of the operations and offering services related to these as an outsourcing service as well. Our extensive nation-wide clinic network offers good conditions to offer, for instance, sample taking services related to screenings for municipalities,” says Ilkka Lehto, Director of the Diagnostics segment. - This acquisition is a considerable increase to Medix Laboratoriot Oy´s operating volume. It enables us to develop the efficiency of the logistical network of the laboratory and that will further improve customer service. The acquisition is a step in Medix´s long-term strategy to build a network of independent central laboratory operations. We cooperate with both private and public partners who produce first-class patient care. Considerable benefits of scale can be achieved by centralizing analytics and this ultimately benefits all players, says Kaj Lybeck, Managing Director of Medix Laboratoriot Oy. Terveystalo's central laboratory located in Tampere is specialized in examinations related to clinical chemistry, hematology and microbiology as well as pathology. FOR ADDITIONAL INFORMATION, PLEASE CONTACT: Suomen Terveystalo Oyj, Managing Director Martti Kiuru, tel. +358 30 633 11 CFO Timo Leinonen, tel. +358 30 633 1649 Medix Laboratoriot Oy, Managing Director Kaj Lybeck, tel. +358 9 525 6257 The release is available at: http://www.terveystalo.com Terveystalo: Suomen Terveystalo is the leading company producing healthcare services in Finland. The company offers healthcare, occupational healthcare and hospital services to private individuals, companies and the public sector through more than 150 offices across Finland. The company, which was founded in 2001, has grown strongly. The company share is listed on the OMX Nordic Exchange Helsinki under the code SUT1V. Medix Laboratoriot Oy: Medix Laboratoriot Oy employs more than 140 laboratory professionals in Espoo and Oulu. Medix Laboratorio is foundation-owned and financially supports medical research activities. Distribution: OMX Nordic Exchange Helsinki Principal media
Terveystalo centralizes its operations and sells its central laboratory to Medix Laboratoriot Oy
| Source: Terveystalo Healthcare Oyj